We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Los Angeles to Host AACC Annual Meeting in July

By HospiMedica staff writers
Posted on 05 Jul 2004
More than 20,000 clinical laboratorians, physicians, research scientists, and other health care professionals will gather in Los Angeles from July 25-29 for the 2004 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC). This year's program includes more than 175 educational sessions that will examine a wide range of clinical laboratory testing developments, including cardiac health risk, cancer detection and treatment, osteoporosis, HIV patient management, patient safety, and drug interaction.

Five plenary lectures will cover a variety of topics, including cutting-edge genetics, proteomics, the role of technology in shaping healthcare, and the future of miniaturized technologies. Meeting sessions will examine the role of herbal medicines and their effects on laboratory tests, the need for clinical facilities to reduce medical errors and patient injuries, prenatal screening, in vitro diagnosis of allergic disorders, and other topics such as women's health, sports nutrition, and cancer diagnosis. Eight sessions will focus on cardiac health and the effects of obesity. More details are available on the website.




Related Links:
AACC

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Newborn Screening Test
NeoMass AAAC 3.0
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests